News of Note—Facebook, flu vaccines and more


Here is some other vaccine news of note for the week:

> Facebook is working to combat the spread of misinformation about vaccines. USA Today article

> From late November to early February, flu vaccines were 47% effective overall in the U.S. in preventing infections. CDC update

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> FDA Commissioner Scott Gottlieb said the federal government might intervene if some states continue on with lax vaccine requirements for schoolchildren. CNN article

> HPV vaccination, together with HPV screening, could end cervical cancer by the end of the 21st century, a new study published in the journal Lancet Oncology has found. The Guardian article

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.